Delivery Order SPE2DR25D2104-SPE2DR26F3RPX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,595.64 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count) on December 4, 2025, with completion scheduled for December 5, 2025. This non-competitive, firm fixed-price delivery order was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The contract represents a single pharmaceutical procurement supporting federal medical supply needs, leveraging AmerisourceBergen's...
- The Defense Logistics Agency awarded a $4,677.35 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packages) on December 11, 2025, with a completion date of December 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $7,553.06 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) with an ultimate completion date of December 9, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive award criteria. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,142.28 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in a 30-count package. This competitively awarded, firm fixed-price contract was executed on December 4, 2025, with an ultimate completion date of December 5, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order represents a single...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count) with a contract ceiling value of $9,131.84. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $2,843.10 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) on December 15, 2025, with an ultimate completion date of December 16, 2025. This competitively awarded, firm fixed-price delivery order was not set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's extensive pharmaceutical...
- The Defense Logistics Agency awarded a $7,484.60 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30 count) on December 11, 2025, with a completion date of December 12, 2025. This is a firm fixed price, non-set-aside contract that leverages AmerisourceBergen's position as a critical pharmaceutical distributor for federal medical procurement. The product will be performed at the company's facility in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $2,288.98 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages). The contract, issued on November 26, 2025, with an ultimate completion date of November 28, 2025, carries firm fixed price terms and was competitively awarded without set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,607.95 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count unit) with a completion date of December 17, 2025. This non-competitive delivery order, awarded on December 16, 2025, utilizes firm fixed-price pricing and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,407.70 for the supply of Ondansetron ODT 4 mg tablets (30-count) on December 9, 2025, with ultimate completion by December 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the company's extensive...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3RPXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,362.92 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packages) on December 16, 2025, with completion scheduled for December 17, 2025. This firm fixed price delivery order, issued without a set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply needs within the Defense Logistics Agency's medical supply chain operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen fulfills diverse medical procurement requirements across multiple therapeutic domains for military and veteran healthcare systems. The broader IDC serves as a comprehensive global pharmaceutical support vehicle enabling delivery of specialty medications, generic and brand-name drugs, vaccines, and related medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 12/15/25 |